Expression of p58.2 or CD94/NKG2a inhibitory receptors in an NK-like cell line, YTINDY, leads to HLA class I-mediated inhibition of cytotoxicity in the p58.2- but not the CD94/NKG2a-expressing transfectant

Cellular Immunology

Volumn 219, Issue 1, 2002, Pages 57-70

  Chua, Hui Lin ^a   Brahmi, Zacharie ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; CD143 ANTIGEN; CD94 ANTIGEN; CELL RECEPTOR; HLA ANTIGEN CLASS 1; LECTIN; PHOSPHATASE; PROTEIN P56; PROTEIN P58 2; PROTEIN TYROSINE PHOSPHATASE SHP 1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; LEUKEMIA CELL LINE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANTIGENS, CD; ANTIGENS, CD94; CARRIER PROTEINS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMEDIATE-EARLY PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; PROTEIN-TYROSINE-PHOSPHATASE; PROTEINS; RECEPTORS, IMMUNOLOGIC; RECEPTORS, MITOGEN; SHP1 PROTEIN TYROSINE PHOSPHATASE; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0036921594     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-8749(02)00578-6     Document Type: Article

References (52)

1. G. Trinchieri, Biology of natural killer cells, Adv. Immunol. 47 (1989) 187-376.
2. K. Kärre, H.-G. Ljunggren, G. Piontek, R. Kiessling, Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy, Nature 319 (1986) 675-678.
3. H.-G. Ljunggren, K. Kärre, In search of the "missing-self": MHC molecules and NK cell recognition, Immunol. Today 11 (1990) 237-244.
4. D. Kaufman, R.A. Schoon, P.J. Liebson, Role for major histocompatibility complex class I in regulating natural killer cell-mediated killing of virus-infected cells, Proc. Natl. Acad. Sci. USA 89 (1992) 8337-8341.
5. A. Hill, P. Jugovic, I. York, G. Russ, J. Benninck, J. Yewdell, H. Ploegh, D. Johnson, Herpes simplex virus turns oN the TAP to evade host immunity, Nature 375 (1995) 411-415.
6. T.R. Jones, L.K. Hanson, L. Sun, J.S. Slater, R.M. Stenberg, A.E. Campbell, Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains, J. Virol. 69 (1995) 4830-4841.
7. W.J. Murphy, C.W. Reynolds, P. Tiberghien, D.L. Longo, Natural killer cells and bone marrow transplantation, J. Nat. Cancer Inst. 85 (1993) 1475-1482.
8. E.O. Long, D.N. Burshtyn, W.P. Clark, M. Peruzzi, S. Rajagopalan, S. Rojo, N. Wagtman, C.C. Winter, Killer inhibitory receptors: Diversity, specificity and function, Immunol. Rev. 155 (1997) 135-144.
9. L.L. Lanier, NK cell receptors, Ann. Rev. Immunol. 16 (1998) 359-393.
10. S. Lazetic, C. Chang, J.P. Houchins, L.L. Lanier, J.H. Phillips, Human natural killer cell receptors involved in MHC Class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits, J. Immunol. 157 (1996) 4741-4745.
11. A.G. Brooks, P.E. Posch, C.J. Scorzelli, F. Borrego, J.E. Coligan, NKG2A complexed with CD94 defines a novel inhibitory natural killer cell receptor, J. Exp. Med. 185 (1997) 795-800.
12. J. Glienke, Y. Sobanov, C. Brostjan, C. Steffens, C. Nguyen, H. Lehrach, E. Hofer, F. Francis, The genomic organization of NKG2C, E, F and D receptor genes in the human natural killer gene complex, Immunogenetics 48 (1998) 163-173.
13. L.L. Lanier, B.C. Corliss, J. Wu, C. Leong, J.H. Phillips, Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells, Nature 391 (1998) 703-707.
14. J. Wu, Y. Song, A.B.H. Bakker, S. Bauer, T. Spies, L.L. Larder, J.H. Phillips, An activating immunoreceptor complex formed by NKG2D and DAP10, Science 285 (1999) 730-732.
15. L.L. Larder, Turning on natural killer cells, J. Exp. Med. 191 (2000) 1259-1262.
16. V.M. Braud, D.S. Allan, C.A. O'Callaghan, K. Soderstrom, A. D'Andrea, G.S. Ogg, S. Lazetic, N.T. Young, J.I. Bell, J.H. Phillips, L.L. Lanier, A.J. McMichael, HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C, Nature 391 (1998) 795-799.
17. A.G. Brooks, F. Borrego, P.E. Posch, A. Patamawenu, C.J. Scorzelli, M. Ulbrecht, E.H. Weiss, J.E. Coligan, Specific recognition of HLA-E, but not classical, HLA Class I molecules by soluble CD94/NKG2A and NK cells, J. Immunol. 162 (1999) 305-313.
18. F. Borrego, M. Ulbrecht, E.H. Weiss, J.E. Coligan, A.G. Brooks, Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA Class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis, J. Exp. Med. 187 (1998) 813-818.
19. N. Lee, M. Llano, M. Carretero, A. Ishitani, F. Navarro, M. López-Botet, D.E. Geraghty, HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A, Proc. Natl. Acad Sci. USA 95 (1998) 5199-5204.
20. E. Ciccone, D. Pende, O. Viale, A. Than, C. Di Donate, A.M. Orengo, R. Biassoni, S. Verdiani, A. Amoroso, A. Moretta, L. Moretta, Involvement of HLA Class I alleles in natural killer (NK) cell-specific functions: Expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (Specificity 2), J. Exp. Med. 176 (1992) 963-971.
21. A. Moretta, M. Vitale, C. Bottino, A.M. Orengo, L. Morelli, R. Auguliaro, M. Barbaresi, E. Ciccone, L. Moretta, P58 molecules as putative receptors for major histocompatibility complex (MHC) Class I molecules in human natural killer(NK) cells. Anti-p58 antibodies reconstitute lysis of MHC Class I-protected cells in NK clones displaying different specificities, J. Exp. Med. 178 (1993) 597-604.
22. lck protein tyrosine kinase with the FcγRIIIA/CD16 complex in human natural killer cells, Eur. J. Immunol. 23 (1993) 2488-2497.
23. lck with FcγRIIIA (CD16) in natural killer cells, J. Exp. Med. 177 (1993) 1475-1480.
24. M. Bléry, J. Delon, A. Trautman, A. Cambiaggi, L. Olcese, R. Biassoni, L. Moretta, P. Chavrier, A. Moretta, M. Daëron, E. Vivier, Reconstituted killer cell inhibitory receptors for major histocompatibility complex class I molecules control mast cell activation induced via immunoreceptor tyrosine-based activation motifs, J. Biol. Chem. 272 (1997) 8989-8996.
25. V. Renard, A. Cambiaggi, F. Vély, M. Bléry, L. Olcese, S. Olivero, M. Bouchet, E. Vivier, Transduction of cytotoxic signals in natural killer cells: A general model of fine tuning between activatory and inhibitory pathways in lymphocytes, Immunol. Rev. 155 (1997) 205-221.
26. H. Nakajima, M. Cella, A. Bouchon, H.L. Grierson, J. Lewis, C.S. Duckett, J.I. Cohen, M. Colonna, Patients with X-linked lymphoproliferative disease have a defect in 2B4-receptor-mediated NK cell cytotoxicity, Eur. J. Immunol. 30 (2000) 3309-3318.
27. B.A. Binstadt, K.M. Brumbaugh, C.J. Dick, A.M. Scharenberg, B.L. Williams, M. Colonna, L.L. Lanier, J.-P. Kinet, R.T. Abraham, P.J. Liebson, Sequential involvement of Lck and SHP-1 with MHC-recognizing receptors on NK cells inhibits FcR-initiated tyrosine kinase activation, Immunity 5 (1996) 629-638.
28. D.N. Burshtyn, A.M. Scharenberg, N. Wagtman, S. Rajagopalan, K. Berrada, T. Yi, J.-P. Kinet, E.O. Long, Recruitment of tyrosine phosphatase HCP by the killer cell inhibitory receptor, Immunity 4 (1996) 77-85.
29. M.C. Nakamura, E.G. Niemi, M.J. Fisher, L.D. Shultz, W.E. Seaman, J.C. Ryan, Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase, J. Exp. Med. 185 (1997) 673-684.
30. A.H. Montel, P.A. Morse, Z. Brahmi, Upregulation of B7 molecules by the Epstein-Barr virus enhances susceptibility to lysis by a human NK-like cell line, Cell. Immunol. 160 (1995) 104-114.
31. lck in the NK cell line YT-Indy, Mol. Immunol. 38 (2001) 495-503.
32. G. Rawadi, D. Lecaque, D. Pirot, S. Roman-Roman, Detection and identification of mycoplasma contamination in cell cultures by polymerase chain reaction, Meth. Mol. Cell. Biol. 4 (1993) 147-156.
33. Z. Brahmi, R.A. Bray, S.I. Abrams, Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanism, J. Immunol. 135 (1985) 4108-4113.
34. P. Matzinger, The JAM test. A simple assay for DNA fragmentation and cell death, J. Immunol. Meth. 145 (1991) 185-192.
35. J.P. Secrist, L.A. Burns, L. Karnitz, G.A. Koretzky, R.T. Abraham, Stimulatory eNects of the protein tyrosine phosphatase inhibitor, pervanadate, on T-cell activation events, J. Biol. Chem. 268 (1993) 5886-5893.
36. O'J.J. Shea, D.W. McVicar, T.L. Bailey, C. Burns, M.J. Smyth, Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation, Proc. Natl. Acad. Sci. USA 89 (1992) 10306-10310.
37. J. Sambrook, E.F. Fritsch, T. Maniatis, in: Molecular Cloning. A Laboratory Manual, Second Ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989, p. 18.56.
38. Y. Shimizu, R. De Mars, Production of human cells expressing individual transferred HLA-A, -B, -C genes using an HLA-A, -B, -C null human cell line, J. Immunol. 142 (1989) 3320-3328.
39. M. Ulbrecht, J. Kellermann, J.P. Johnson, E.H. Weiss, Impaired intracellular transport and cell surface expression of nonpolymorphic HLA-E: Evidence for inefficient peptide binding, J. Exp. Med. 176 (1992) 1083-1090.
40. V. Braud, E.Y. Jones, A. McMichael, The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9, Eur. J. Immunol. 27 (1997) 1164-1169.
41. C. Watzl, C.C. Stebbins, E.G. Long, NK cell inhibitory receptors prevent tyrosine phosphorylation of the activating receptor 2B4 (CD244), J. Immunol. 165 (2000) 3545-3548.
42. S. Rajagopalan, E.O. Long, A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells, J. Exp. Med. 189 (1999) 1093-1099.
43. B. Lowin-Kopf, B. Kunz, F. Beermann, W. Held, Impaired natural killing of MHC Class I-deficient targets by NK cells expressing a catalytically inactive form of SHP-1, J. Immunol. 165 (2000) 1314-1321.
44. L. Olcese, P. Lang, F. V3 ely, A. Cambiaggi, D. Marguet, M. Bl3 ery, K.L. Hippen, R. Biassoni, A. Moretta, L. Moretta, J.C. Cambier, E. Vivier, Human and mouse killer-cell inhibitory receptors recruit PTP1C and PTP1D protein tyrosine phosphatases, J. Immunol. 156 (1996) 4531-4534.
45. E. Le Dréan, F. Vely, L. Olcese, A. Cambiaggi, S. Guia, G. Krystal, N. Gervois, A. Moretta, F. Jotereau, E. Vivier, Inhibition of antigen-induced T cell response and antibody-induced NK cell cytotoxicity by NKG2A: Association of NKG2A with SHP-1 and SHP-2 protein-tyrosine phosphatases, Eur. J. Immunol. 28 (1998) 264-276.
46. M. Carretero, G. Palmieri, M. Llano, V. Tullio, A. Santoni, D.E. Geraghty, M. López-Botet, Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: Evidence for receptor function in heterologous transfectants, Eur. J. Immunol. 28 (1998) 1280-1291.
47. T. Niu, X. Liang, J. Yang, Z. Zhao, G.W. Zhou, Kinetic comparison of the catalytic domains of SHP-1 and SHP-2, J. Cell. Biochem. 72 (1999) 145-150.
48. G.G. Chiang, B.M. Sefton, Specific dephosphorylation of the lck tyrosine protein kinase at Tyr 394 by the SHP-1 protein tyrosine phosphatase, J. Biol. Chem. 276 (2001) 23173-23178.
49. G. Palmieri, V. Tullio, A. Zingoni, M. Piccoh, L. Frati, M. López-Botet, A. Santoni, CD94/NKG2-A inhibitory complex blocks CD16-triggered Syk and extiacellular regulated kinase activation, leading to cytotoxic function of human NK cells, J. Immunol. 162 (1999) 7181-7188.
50. J. Sayós, K.B. Nguyen, C. Wu, S.E. Stepp, D. Howie, J.D. Schatzle, V. Kumar, C.A. Biron, C. Terhorst, Potential pathways for regulation of NK and T cell responses: Differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4, Int. Immunol. 12 (2000) 1749-1757.
51. J.P. Houchins, T. Yabe, C. McSherry, F.H. Bach, DNA sequence analysis of NKG2, a family of related cDNA clones encoding Type II integral membrane proteins on human natural killer cells, J. Exp. Med. 173 (1991) 1017-1020.
52. C. Cantoni, R. Biassoni, D. Pende, S. Sivori, L. Accame, L. Pareti, G. Semenzato, L. Moretta, A. Moretta, C. Bottino, The activating form of CD94 receptor complex: CD94 covalently associates with the Kp39 protein that represents the product of the NKG2-C gene, Eur. J. Immunol. 28 (1998) 327-338.